← Leaderboards
Daniel D Von Hoff
University Of Texas Hlth Sci Ctr San Ant
$23,238,156
Attributed
$28,203,396
Total exposure
13
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.8M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$50,858,956 · 15
By mechanism
P01$23,327,001 · 5
U01$7,986,946 · 1
P30$7,429,324 · 1
R25$6,676,785 · 2
R01$5,406,082 · 3
M01$32,818 · 2
Top collaborators
- Ajay Goel10 shared
- Haiyong Han5 shared
Most similar at University Of Texas Hlth Sci Ctr San Ant
Same institution · by research overlap
- Joseph K Agyin$1,223,967
- Kenneth Cusi$1,000,345
- H. Ralph Rawls$4,146,635
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsClinical TrialsMalignant Neoplasm Of PancreasDesignEvaluationResearch PersonnelGenesSuccessCessation Of LifeBasePancreasLeadTumorNew AgentsCancer PatientParticipantNovel TherapeuticsGrantProgramsTrainingCancer EtiologyCellsCancer CellPrevention
Grant awards (79)
Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer$861,010
U01 · FY2025 · CA
Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer$13,525
U01 · FY2025 · CA
Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer$13,525
U01 · FY2025 · CA
Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer$815,080
U01 · FY2024 · CA
Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer$923,881
U01 · FY2023 · CA
Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer$1,445,861
U01 · FY2021 · CA
Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer$718,747
U01 · FY2020 · CA
Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer$1,099,737
U01 · FY2019 · CA
Methods in Clinical Cancer Research Workshop$224,999
R25 · FY2019 · CA · contact PI
Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer$1,020,224
U01 · FY2018 · CA
Methods in Clinical Cancer Research Workshop$224,999
R25 · FY2018 · CA · contact PI
Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer$1,075,356
U01 · FY2017 · CA
Targeting Stromal Collagen in Pancreatic Cancer$386,727
R01 · FY2017 · CA
Methods in Clinical Cancer Research Workshop$224,999
R25 · FY2017 · CA · contact PI
Targeting Stromal Collagen in Pancreatic Cancer$386,727
R01 · FY2016 · CA
Methods in Clinical Cancer Research Workshop$224,999
R25 · FY2016 · CA · contact PI
Targeting Stromal Collagen in Pancreatic Cancer$386,727
R01 · FY2015 · CA
Targeting Stromal Collagen in Pancreatic Cancer$375,126
R01 · FY2014 · CA
Methods in Clinical Cancer Research Workshop$80,000
R25 · FY2014 · CA · contact PI
Methods in Clinical Cancer Research Workshop$410,422
R25 · FY2013 · CA · contact PI
Targeting Stromal Collagen in Pancreatic Cancer$408,227
R01 · FY2013 · CA
Methods in Clinical Cancer Research Workshop$291,748
R25 · FY2012 · CA · contact PI
Methods in Clinical Cancer Research Workshop$291,748
R25 · FY2011 · CA · contact PI
Aurora Kinases as Therapeutic Targets in Pancreatic Cancer$316,242
R01 · FY2010 · CA · contact PI
Methods in Clinical Cancer Research Workshop$283,251
R25 · FY2010 · CA · contact PI
Targets to Therapeutics in Pancreatic Cancer$3,046,343
P01 · FY2009 · CA · contact PI
Drug Development Core$890,415
P01 · FY2009 · CA · contact PI
Pancreas Cancer Biospecimens Repository$594,851
P01 · FY2009 · CA · contact PI
Aurora Kinases as Therapeutic Targets in Pancreatic Cancer$314,790
R01 · FY2009 · CA · contact PI
Methods in Clinical Cancer Research Workshop$275,000
R25 · FY2009 · CA · contact PI
Method to Eliminate Pancreatic Cells with Specific Patterns of Mutations/Deletion$243,978
P01 · FY2009 · CA · contact PI
Targets to Therapeutics in Pancreatic Cancer$2,968,687
P01 · FY2008 · CA · contact PI
Drug Development Core$866,135
P01 · FY2008 · CA · contact PI
Pancreas Cancer Biospecimens Repository$581,812
P01 · FY2008 · CA · contact PI
Aurora Kinases as Therapeutic Targets in Pancreatic Cancer$293,406
R01 · FY2008 · CA · contact PI
Clinical Trials Methods Workshop - Europe$277,470
R25 · FY2008 · CA · contact PI
Workshop on Methods in Clinical Cancer Research$271,013
R25 · FY2008 · CA · contact PI
Method to Eliminate Pancreatic Cells with Specific Patterns of Mutations/Deletion$237,596
P01 · FY2008 · CA · contact PI
Targets to Therapeutics in Pancreatic Cancer$3,129,737
P01 · FY2007 · CA · contact PI
Drug Development Core$849,648
P01 · FY2007 · CA · contact PI
Pancreas Cancer Biospecimens Repository$760,152
P01 · FY2007 · CA · contact PI
Aurora Kinases as Therapeutic Targets in Pancreatic Cancer$305,898
R01 · FY2007 · CA · contact PI
Clinical Trials Methods Workshop - Europe$269,388
R25 · FY2007 · CA · contact PI
Workshop on Methods in Clinical Cancer Research$263,120
R25 · FY2007 · CA · contact PI
Method to Eliminate Pancreatic Cells with Specific Patterns of Mutations/Deletion$259,180
P01 · FY2007 · CA · contact PI
Targets to Therapeutics in Pancreatic Cancer$2,988,784
P01 · FY2006 · CA · contact PI
Drug Development Core$667,177
P01 · FY2006 · CA · contact PI
Pancreas Cancer Biospecimens Repository$443,418
P01 · FY2006 · CA · contact PI
Aurora Kinase as a Therapeutic Target in Cancer$325,205
R01 · FY2006 · CA · contact PI
Clinical Trials Methods Workshop - Europe$269,352
R25 · FY2006 · CA · contact PI
Workshop on Methods in Clinical Cancer Research$263,086
R25 · FY2006 · CA · contact PI
Method to Eliminate Pancreatic Cells with Specific Patterns of Mutations/Deletion$204,605
P01 · FY2006 · CA · contact PI
Targets to Therapeutics in Pancreatic Cancer$3,092,685
P01 · FY2005 · CA
Drug Development Core$663,716
P01 · FY2005 · CA
Pancreas Cancer Biospecimens Repository$466,274
P01 · FY2005 · CA
Aurora Kinase as a Therapeutic Target in Cancer$354,542
R01 · FY2005 · CA
Clinical Trials Methods Workshop - Europe$267,800
R25 · FY2005 · CA
Workshop on Methods in Clinical Cancer Research$261,570
R25 · FY2005 · CA
Evaluation and Administrative Core$191,097
P01 · FY2005 · CA
Method to Eliminate Pancreatic Cells with Specific Patterns of Mutations/Deletion$180,711
P01 · FY2005 · CA
Aurora Kinase as a Therapeutic Target in Cancer$303,379
R01 · FY2004 · CA
Clinical Trials Methods Workshop - Europe$260,000
R25 · FY2004 · CA
Workshop on Methods in Clinical Cancer Research$253,951
R25 · FY2004 · CA
Aurora Kinase as a Therapeutic Target in Cancer$303,379
R01 · FY2003 · CA
METHODS IN CLINICAL CANCER RESEARCH$246,555
R25 · FY2003 · CA
CANCER CENTER SUPPORT GRANT$2,434,264
P30 · FY2002 · CA
Aurora Kinase as a Therapeutic Target in Cancer$303,379
R01 · FY2002 · CA
METHODS IN CLINICAL CANCER RESEARCH$239,530
R25 · FY2002 · CA
MOLECULAR TARGETS IN COLORECTAL AND PANCREATIC CANCERS$0
P50 · FY2002 · CA
CANCER CENTER SUPPORT GRANT$2,531,456
P30 · FY2001 · CA
NOVEL A RING AND E RING MODIFIED CAMPTOTHECIN ANALOGS$325,911
R01 · FY2001 · CA
METHODS IN CLINICAL CANCER RESEARCH (EUROPE): A WORKSHOP$277,301
R25 · FY2001 · CA
METHODS IN CLINICAL CANCER RESEARCH$232,711
R25 · FY2001 · CA
CANCER CENTER SUPPORT GRANT$2,463,604
P30 · FY2000 · CA
NOVEL A RING AND E RING MODIFIED CAMPTOTHECIN ANALOGS$316,417
R01 · FY2000 · CA
METHODS IN CLINICAL CANCER RESEARCH (EUROPE): A WORKSHOP$265,684
R25 · FY2000 · CA
METHODS IN CLINICAL CANCER RESEARCH$226,089
R25 · FY2000 · CA
PHASE I CLINICAL AND PHARMACOKINETIC EVALUATION OF LY295501$16,409
M01 · FY2000 · RR
PHASE I TRIAL OF RHIZOXIN ADMINISTERED AS A 72 HR IV INFUSION$16,409
M01 · FY2000 · RR